Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-08
DOI
10.3389/fendo.2019.00884
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment-related adverse effects with TKIs in patients with advanced or radioiodine refractory differentiated thyroid carcinoma: a systematic review and meta-analysis
- (2019) Shi-Tong Yu et al. Cancer Management and Research
- Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer:
- (2019) R Michael Tuttle et al. THYROID
- Prolongation of tumour volume doubling time (midDT) is associated with improvement in disease-specific survival in patients with rapidly progressive radioactive iodine refractory differentiated thyroid cancer selected for molecular targeted therapy
- (2019) Mona M. Sabra et al. CLINICAL ENDOCRINOLOGY
- Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
- (2019) Janice M. Mehnert et al. BMC CANCER
- The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition
- (2019) Gilda Varricchi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan
- (2019) Iwao Sugitani et al. THYROID
- Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center
- (2019) Eleonora Molinaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients
- (2018) Rajshri M. Gartland et al. ANNALS OF SURGICAL ONCOLOGY
- Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancer
- (2018) Jaume Capdevila et al. CANCER TREATMENT REVIEWS
- Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance
- (2018) Akira Miyauchi et al. SURGERY
- Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice
- (2018) Amandine Berdelou et al. THYROID
- Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option
- (2018) Yasuhiro Ito et al. THYROID
- Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies
- (2018) F. Pacini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications
- (2018) Douglas Van Nostrand THYROID
- NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
- (2018) Robert I. Haddad et al. Journal of the National Comprehensive Cancer Network
- Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
- (2018) Maria E. Cabanillas et al. SEMINARS IN ONCOLOGY
- Response to Letter: “Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation”
- (2017) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center’s Experience in Korea
- (2017) Hyemi Kwon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial
- (2017) Marcia S. Brose et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
- (2017) R. Michael Tuttle et al. JAMA Otolaryngology-Head & Neck Surgery
- Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
- (2016) Denise P. Momesso et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital
- (2016) Yasuhiro Ito et al. THYROID
- A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma
- (2016) Juan P. Brito et al. THYROID
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma
- (2015) Yorihisa Orita et al. ANNALS OF SURGICAL ONCOLOGY
- Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer
- (2015) R.L. Cazzato et al. EJSO
- Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation
- (2015) Gabriela Franco Mourão et al. ENDOCRINE-RELATED CANCER
- Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer
- (2015) Ewa Ruel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiofrequency Ablation to Treat Loco-Regional Recurrence of Well-Differentiated Thyroid Carcinoma
- (2014) Sun Jin Lee et al. KOREAN JOURNAL OF RADIOLOGY
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients
- (2013) Maria Grazia Castagna et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- (2013) Mingzhao Xing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up
- (2013) Eleonora Molinaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected “recurrent” neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy
- (2013) Ian D. Hay et al. SURGERY
- Patient Age Is Significantly Related to the Progression of Papillary Microcarcinoma of the Thyroid Under Observation
- (2013) Yasuhiro Ito et al. THYROID
- Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
- (2012) Claire Schvartz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment
- (2012) Ralph P. Tufano et al. MEDICINE
- Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
- (2012) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
- (2012) Ujjal Mallick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer— is there a need for radioactive iodine therapy?
- (2012) Tihana Ibrahimpasic et al. SURGERY
- Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment
- (2012) Ji Min Han et al. THYROID
- Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients
- (2011) Hadiza S. Kazaure et al. ANNALS OF SURGICAL ONCOLOGY
- Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients
- (2011) Maria Grazia Castagna et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer
- (2011) Iain J. Nixon et al. SURGERY
- Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
- (2011) Akira Miyauchi et al. THYROID
- Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
- (2010) D. Deandreis et al. ENDOCRINE-RELATED CANCER
- Does Postoperative Thyrotropin Suppression Therapy Truly Decrease Recurrence in Papillary Thyroid Carcinoma? A Randomized Controlled Trial
- (2010) Iwao Sugitani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Benefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid Cancer
- (2010) Bernadette Biondi et al. THYROID
- Radioiodine Therapy in Patients with Stage I Differentiated Thyroid Cancer
- (2010) Jacqueline Jonklaas et al. THYROID
- The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008
- (2010) Wendy Sacks et al. THYROID
- Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
- (2010) R. Michael Tuttle et al. THYROID
- No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
- (2009) Frederik Anton Verburg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Thyroid hormone replacement after thyroid lobectomy
- (2009) Samantha J. Stoll et al. SURGERY
- Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
- (2009) Sally E. Carty et al. THYROID
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients
- (2009) Yasuhiro Ito et al. WORLD JOURNAL OF SURGERY
- Consensus Statement on the Classification and Terminology of Neck Dissection
- (2008) K. Thomas Robbins et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
- (2008) D. Taïeb et al. CLINICAL ENDOCRINOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen
- (2008) I. Borget et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
- (2008) R. M. Tuttle et al. JOURNAL OF NUCLEAR MEDICINE
- Prospective Outcomes of Selective Lymph Node Dissection for Papillary Thyroid Carcinoma Based on Preoperative Ultrasonography
- (2008) Iwao Sugitani et al. WORLD JOURNAL OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now